MAL2 knockdown inhibited cancer cell migration, invasion, and promoted apoptosis in vitro, and inhibited tumor metastasis in vivo possibly by regulating the EMT and β-catenin/c-Myc pathway. This evidence concerns the gene MYC and cancer.